Respiratory disease and early serum S100A12 changes in very premature infants

Acta Paediatrica, International Journal of Paediatrics

Volumn 100, Issue 12, 2011, Pages 1538-1543

  Loughran Fowlds, Alison ^a,b,c   Leach, Steven ^a   Lin, Jianwei ^b   Oei, Julee ^a,b   Henry, Richard ^a   Day, Andrew S ^a,d   Lui, Kei ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL HOSPITAL FOR WOMEN   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bronchopulmonary dysplasia; Corticosteroids; Neonatal respiratory distress syndrome; Premature infants; S 100 protein

Indexed keywords

CALCIUM BINDING PROTEIN; CORTICOSTEROID; INTERLEUKIN 6; INTERLEUKIN 8; LUNG SURFACTANT; S100A12 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CHORIOAMNIONITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ESCHERICHIA COLI; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; NEWBORN; PERINATAL PERIOD; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTE COUNT; LOGISTIC MODELS; NEUTROPHILS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; S100 PROTEINS;

EID: 80855131452     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2011.02384.x     Document Type: Article

References (30)

1. Jobe AH, Bancalari E,. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-9. (Pubitemid 32578778)
2. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97: 889-901. (Pubitemid 29375048)
3. Foell D, Seeliger S, Vogl T, Koch HG, Maschek H, Harms E, et al., Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 2003; 58: 613-7. (Pubitemid 36808133)
4. Belessis Y, Leach S, Hawkins G, Numa A, Morton J, Lui K, et al., Serum A12 and calprotectin are associated with airway infection in young children with CF and are potential non-invasive markers of early lung disease. The Thoracic Society of Australia and New Zealand 2006.
5. Yang Z, Yan WX, Cai H, Tedla N, Armishaw C, Di Girolamo N, et al., S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. J Allergy Clin Immunol 2007; 119: 106-14. (Pubitemid 46037791)
6. Lorenz E, Muhlebach MS, Tessier PA, Alexis NE, Duncan Hite R, Seeds MC, et al., Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respir Med 2008; 102: 567-73.
7. Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, van der Poll T, Hoidal JR, et al., Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 2007; 35: 1369-75. (Pubitemid 46642668)
8. Buhimschi CS, Buhimschi IA, Abdel-Razeq S, Rosenberg VA, Thung SF, Zhao G, et al., Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res 2007; 61: 318-24.
9. Buhimschi CS, Dulay AT, Abdel-Razeq S, Zhao G, Lee S, Hodgson EJ, et al., Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. Br J Obstet Gynaecol 2009; 116: 257-67.
10. Leach ST, Messina I, Yang Z, Song C, Cunningham A, Geczy C, et al., Serum and mucosal calprotectin (S100 A8/A9) and S100A12 are elevated in children with inflammatory bowel disease (IBD). J Gastroenterol Hepatol 2004; 19: A278.
11. De Jong NSH, Leach ST, Day AS,. Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. Inflamm Bowel Dis 2006; 12: 566-72. (Pubitemid 43977737)
12. Foell D, Frosch M, Sorg C, Roth J,. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004; 344: 37-51. (Pubitemid 38626135)
13. Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, et al., Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology 2003; 42: 1383-9. (Pubitemid 37407031)
14. Leach ST, Mitchell HM, Geczy CL, Sherman PM, Day AS,. S100 calgranulin proteins S100A8, S100A9 and S100A12 are expressed in the inflamed gastric mucosa of Helicobacter pylori-infected children. Can J Gastroenterol 2008; 22: 461-4. (Pubitemid 351943674)
15. Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, et al., Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003; 52: 847-53. (Pubitemid 36613492)
16. Stuart A, Edvinsson L, Kallen K, Olofsson P, Hellsten C, Amer-Wahlin I,. Fetal electrocardiographic monitoring during labor in relation to cord blood levels of the brain-injury marker protein S-100. J Perinat Med 2008; 36: 136-41. (Pubitemid 351364304)
17. Buhimschi CS, Bhandari V, Han YW, Dulay AT, Baumbusch MA, Madri JA, et al., Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future. Curr Opin Infect Dis 2009; 22: 235-43.
18. Ferreira PJ, Bunch TJ, Albertine KH, Carlton DP,. Circulating neutrophil concentration and respiratory distress in premature infants. J Pediatr 2000; 136: 466-72. (Pubitemid 30469587)
19. Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Magloire LK, Thung S, et al., The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol 2007; 196: 181.e1-13.
20. Yang Q, Smith PB, Goldberg RN, Cotten CM,. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology 2008; 94: 267-71.
21. Kramer BW, Jobe AH,. The clever fetus: responding to inflammation to minimize lung injury. Biol Neonate 2005; 88: 202-7. (Pubitemid 41433552)
22. Manolakis AC, Kapsoritakis AN, Georgoulias P, Tzavara C, Valotassiou V, Kapsoritaki A, et al., Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol 2010; 10: 118.
23. Mori Y, Kosaki A, Kishimoto N, Kimura T, Iida K, Fukui M, et al., Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis. Am J Nephrol 2009; 29: 18-24.
24. Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL,. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001; 69: 986-94. (Pubitemid 32577902)
25. Hermans C, Bernard A,. Pneumoproteinaemia: a new perspective in the assessment of lung disorders. Eur Respir J 1998; 11: 801-3. (Pubitemid 28231269)
26. Loughran-Fowlds A, Oei J, Wang H, Xu H, Wimalasundera N, Egan C, et al., The influence of gestation and mechanical ventilation on serum Clara cell secretory protein (CC10) concentrations in ventilated and nonventilated newborn infants. Pediatr Res 2006; 60: 103-8. (Pubitemid 44297622)
27. Kotecha S,. Cytokines in chronic lung disease of prematurity. Eur J Pediatr 1996; 155: S14-7.
28. Paananen R, Husa A-K, Vuolteenaho R, Herva R, Kaukola T, Hallman M,. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 2009; 154: 39-43.e3.
29. Choi CW, Kim BI, Kim H-S, Park JD, Choi J-H, Son DW,. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta Paediatr 2006; 95: 38-43. (Pubitemid 43041726)
30. Been JV, van Iwaarden FJ, de Jager W, Debeer A, Prakken BJ, Zimmermann LJ,. Pulmonary chemokine and cytokine profiles in ventilated preterm infants. Vancouver: Pediatric Academic Society, 2010.